Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03533283 |
|---|---|
| Brief Title: | An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma |
| First Submitted : | May 4, 2018 |
| First Submitted that Met QC Criteria : | May 11, 2018 |
| First Posted : | May 23, 2018 |
| Last Update Submitted that Met QC Criteria : | March 17, 2023 |
| Last Update Posted : | March 20, 2023 |